Influence of Vitamin C on Post-operative Atrial Fibrillation

Atrial Fibrillation Clinical Trial

Official title: Influence of Oral Vitamine C Supplementation on the Incidence of Post-operative Atrial Fibrillation

Status Recruiting

Clinical Trial Summary

Post-operative atrial fibrillation (POAF) is the most common arrhythmia which typically develops 2-3 days after cardiac surgery. The incidence of POAF variates between 10% and 65% depending on the type of cardiac surgery and is especially high in patients which underwent Coronary Artery Bypass Grafting (CABG) and heart valve surgery. POAF is associated with increased morbidity and mortality and has a major impact on hospital resources.

The precise pathogenesis of POAF is very complex, but several studies have demonstrated an association between inflammation, oxidative stress and POAF. Since this oxidative stress may be reduced by dietary anti-oxidantia such as vitamin C, the aim of this study is to evaluate the effect of oral vitamin C administration of the incidence of POAF.

Clinical Trial Description

After obtaining informed consent, patients which are planned for CABG or heart valve surgery are randomly assigned into the Vitamin C group or Placebo Group.

Each patient will receive 1 g Vitamin C or Placebo twice a day from 5 days before until 10 days after surgery. The medication will be given orally and both patient and surgeon are blinded for the administrated medication.

Patients receive standard of care in the post-operative period, which includes close monitoring for possible arrhythmias. If such an arrhythmia develops, this is treated according to the normal procedures. All information such as the used medication, the hospitalization / ICU length of stay and the ventilation time is automatically registered in the patient records.

From each patient, three additional blood samples (peri-operative, post-operative Day 0, post-operative Day 1) will be obtained for analysis of Neutrophil gelatinase-associated lipocalin (NGAL), a possible marker of subclinical kidney damage. These samples will be analysed in batch once all samples are collected. ;

Related Conditions & MeSH terms

• Atrial Fibrillation

• NCT number: NCT03592680
• Study type: Interventional
• Source: Algemeen Ziekenhuis Maria Middelares
• Contact: Alain F Kalmar, MD,PhD,MSc
• Phone: +32 246 17 00
• Email: alain.kalmar@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2018
• Completion date: June 2021